Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05884320 |
|---|---|
| Brief Title: | Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers |
| First Submitted : | May 22, 2023 |
| First Submitted that Met QC Criteria : | May 22, 2023 |
| First Posted : | June 1, 2023 |
| Last Update Submitted that Met QC Criteria : | February 13, 2024 |
| Last Update Posted : | February 15, 2024 |